Literature DB >> 27018238

Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital.

Michael Kueht1, Patrick Thompson2, Abbas Rana1, Ronald Cotton1, Christine O'Mahony1, John Goss1.   

Abstract

The purposes of this study were to analyze the effects of an ERS on time to transplantation and to describe our center's experience with OLT for HB. Patients who received OLT for HB between 2000 and 2013 were included. Patient and allograft characteristics, chemotherapy regimens, and prior surgical therapies were examined. The interval between diagnosis and OLT prior to and following the institution of an ERS for transplant was compared. Survival and tumor recurrence were analyzed. Nineteen patients received OLT for HB (mean age 33 months). All children received grafts from deceased donors. Two patients underwent prior resections. Tumor recurred in four patients (21.1%). Both patients who received salvage transplants experienced post-OLT recurrence. Three of the four recurrences occurred in spite of adjuvant chemotherapy. There were three deaths: two from metastatic disease. One- and five-yr survivals were 86.1% and 73.8%. After the institution of the ERS, the mean interval between tissue diagnosis and OLT was significantly reduced. Our series of 19 patients demonstrates a 21% recurrence of HB following OLT despite chemotherapy. Five-yr survival reached 73.8%. A system of early referral can effectively reduce times between diagnosis and transplant.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatoblastoma; liver transplant; neoadjuvant chemotherapy

Mesh:

Substances:

Year:  2016        PMID: 27018238     DOI: 10.1111/petr.12699

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

Review 1.  Unresectable hepatoblastoma: current perspectives.

Authors:  Angela D Trobaugh-Lotrario; Rebecka L Meyers; Allison F O'Neill; James H Feusner
Journal:  Hepat Med       Date:  2017-02-01

Review 2.  How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.

Authors:  Roberta Angelico; Chiara Grimaldi; Carlo Gazia; Maria Cristina Saffioti; Tommaso Maria Manzia; Aurora Castellano; Marco Spada
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

3.  Feasibility of Real-Time Central Surgical Review for Patients with Advanced-Stage Hepatoblastoma in the JPLT3 Trial.

Authors:  Tomoro Hishiki; Shohei Honda; Yuichi Takama; Yukihiro Inomata; Hideaki Okajima; Ken Hoshino; Tatsuya Suzuki; Ryota Souzaki; Motoshi Wada; Mureo Kasahara; Koichi Mizuta; Takaharu Oue; Akiko Yokoi; Takuro Kazama; Shugo Komatsu; Isamu Saeki; Osamu Miyazaki; Tetsuya Takimoto; Kohmei Ida; Kenichiro Watanabe; Eiso Hiyama
Journal:  Children (Basel)       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.